Navigation Links
Tart Cherries May Reduce Inflammation, Lower Risk for Type 2 Diabetes & Heart Disease
Date:4/6/2008

New Study Reinforces Anti-Inflammatory Properties of Red Hot 'Super Fruit'

SAN DIEGO, April 6, 2008 /PRNewswire/- A new study shows tart cherries, one of today's hottest "Super Fruits," may help reduce inflammation, potentially lowering the risk of type 2 diabetes and cardiovascular disease in animals. The study was presented by University of Michigan researchers today at the Experimental Biology annual meeting. As science continues to reveal inflammation may be a marker for many chronic diseases, the researchers say emerging studies like this are important in examining the role diet may play in disease management and prevention.

At-risk rats with metabolic syndrome (obese, pre-diabetic) and lean, healthy rats were fed a cherry-enriched "Western Diet," characterized by high fat and moderate carbohydrate -- in line with the typical American diet. Cherry-enriched diets, which consisted of whole tart cherry powder as 1 percent of the diet, reduced two known markers of inflammation by up to 50 percent. TNF-alpha was reduced by 50 percent in the lean rats and 40 percent in the at-risk rats and interleukin 6 (IL-6) was lowered by 31 percent in the at-risk rats and 38 percent in the lean rats.

While inflammation is a normal process the body uses to fight off infection or injury, according to recent science, a chronic state of inflammation could increase the risk for diseases.

"We're learning how important reducing inflammation is for our overall health and lowering the risk for heart disease and type 2 diabetes -- two of the most critical health epidemics we have in this country today," said study co-author Dr. Steven F. Bolling, a cardiac surgeon at the University of Michigan Cardiovascular Center who also heads the U-M Cardioprotection Research Laboratory, where the study was performed. "This study offers further promise that foods rich in antioxidants, such as cherries, could potentially reduce inflammation and lower disease risk." '/>"/>

SOURCE The Cherry Marketing Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CV Therapeutics Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
2. Lotrel, a Single-Pill Combination for Treating High Blood Pressure, Reduced Cardiovascular Events by 20% in High-Risk Patients
3. Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimers Disease
4. Reduced Lung Capacity Accelerates With Diabetes
5. Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases
6. Medivations Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimers Disease Patients, Resulting in Reduced Caregiver Distress
7. Recent Studies Suggest Popular Diet Pill Relacore Reduces Acne Breakouts
8. Breast Cancer Treatment Is Reduced to One Week
9. Study Says Allergy Shots Help Children, Reduce Health Care Costs
10. Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
11. New Implantable Lenses Can Reduce the Need for Glasses After Cataract Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Dynatronics Receives 180-Day NASDAQ Extension 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3Caltech researchers show efficacy of gene therapy in mouse models of Huntingtons disease 10594 1Caltech researchers show efficacy of gene therapy in mouse models of Huntingtons disease 10594 2AAPD Featured on CBS Jumbo Screen in Times Square 60421 1AAPD Featured on CBS Jumbo Screen in Times Square 60421 2The Childrens Hospital of Philadelphia Appoints New Chief Nursing Officer 60416 1The Childrens Hospital of Philadelphia Appoints New Chief Nursing Officer 60416 2
Breaking Medicine News(10 mins):Health News:Rush Limbaugh & Michael Steele Join Tea Party Support & Social Security Institute-Demand GOP Senate Stop ObamaCare by Any Means Possible 2Health News:Rush Limbaugh & Michael Steele Join Tea Party Support & Social Security Institute-Demand GOP Senate Stop ObamaCare by Any Means Possible 3Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 2Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 3Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 4Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 5Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 6Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 7Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 8Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 9Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 10Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 11Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 12Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 13Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 14Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 15Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 16Health News:Chinese-American and Korean-American women at highest risk for diabetes in pregnancy 2Health News:Chinese-American and Korean-American women at highest risk for diabetes in pregnancy 3Health News:Therapure Biopharma Inc. and Akorn, Inc. Announce Strategic Supply Contract 2Health News:Luckey & Mullins Joins with Other National Construction Defect Law Firms to Form Chinese Drywall Legal Network 2